Mike Hennessy Jr, Chairman and CEO, MJH Life Sciences
Advertisement
Articles by Mike Hennessy Jr, Chairman and CEO, MJH Life Sciences
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Treatment interruptions in prostate cancer: Balancing PSA kinetics and quality of life
2
FDA approves durvalumab plus enfortumab vedotin for cisplatin-ineligible MIBC
3
FDA grants breakthrough therapy designation to 64Cu-SAR-bisPSMA for recurrent prostate cancer imaging
4
The UroOnc Minute: The Role of Language in Cancer Care, With Jessica Rett, PhD
5
